Johannes Fruehauf Ph.D

Johannes Fruehauf Ph.D General Information

Biography

Dr. Johannes Fruehauf is a Co-Founder and serves as Chief Executive Officer, President, Board Member, and Executive Director at LabCentral. He is a Co-Founder and serves as General Partner at Mission BioCapital. He is the Founder and serves as Chief Executive Officer and President at BioLabs. He co-founded and served as Chief Scientific Officer & Chairman at ViThera Pharmaceuticals. He served as Board Member at BioMolecular Therapeutics and Sentien. He is a Co-Founder and serves as Chief Executive Officer & President at BioLabs (San Diego). He serves as Board Member at QurAlis. He serves as Board Observer at Pandion Therapeutics.He is a physician and serial biotech entrepreneur. He served as Board Member at Mitokinin. At Mission BioCapital, he sources, diligences, and leads new investment transactions. Through his role at LabCentral and Cambridge BioLabs, and his connections at Harvard, MassChallenge, MassBio, and MIT, he is currently in touch with a preponderance of the early-stage life sciences investment opportunities in the Boston/Cambridge ecosystem. He has a long track record of building successful research organizations. He is a Co-Founder at Deltix and served as a consultant to a number of biotechnology companies and non-profits, including Aura Biosciences, Izon, Advirna, and Unitio. He is the author of over 30 peer-reviewed publications and is named inventor on 9 patents. He earned his medical degree at the University of Frankfurt and his Ph.D. at the University of Heidelberg (Germany). He serves as Board Member at Alaya.bio and Arkuda Therapeutics.